BOLOGNA, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 6.928
EU - Europa 4.177
AS - Asia 2.467
Continente sconosciuto - Info sul continente non disponibili 13
SA - Sud America 11
OC - Oceania 9
AF - Africa 3
Totale 13.608
Nazione #
US - Stati Uniti d'America 6.914
IE - Irlanda 1.253
CN - Cina 1.108
TR - Turchia 853
SE - Svezia 690
DE - Germania 538
GB - Regno Unito 434
SG - Singapore 429
UA - Ucraina 418
IT - Italia 366
FI - Finlandia 234
FR - Francia 162
IN - India 47
BE - Belgio 24
CA - Canada 13
RU - Federazione Russa 13
EU - Europa 11
CZ - Repubblica Ceca 8
NL - Olanda 8
AU - Australia 7
BR - Brasile 7
KR - Corea 7
IL - Israele 6
ES - Italia 4
MA - Marocco 3
PL - Polonia 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AT - Austria 2
BD - Bangladesh 2
BG - Bulgaria 2
HU - Ungheria 2
JP - Giappone 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PE - Perù 2
RS - Serbia 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AL - Albania 1
AR - Argentina 1
BN - Brunei Darussalam 1
CH - Svizzera 1
HK - Hong Kong 1
ME - Montenegro 1
MX - Messico 1
NO - Norvegia 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
UZ - Uzbekistan 1
Totale 13.608
Città #
Jacksonville 1.671
Chandler 1.324
Dublin 1.251
Boardman 541
Izmir 419
Singapore 351
Nanjing 349
San Mateo 334
Wilmington 258
Santa Clara 214
Lawrence 209
Princeton 209
Ann Arbor 194
New York 157
Nanchang 123
Beijing 103
Milan 102
Woodbridge 93
Bremen 83
Seattle 83
Shenyang 83
Ashburn 73
Verona 71
Hebei 58
Des Moines 56
Mountain View 53
Jiaxing 52
Kunming 47
L'aquila 46
Tianjin 45
Changsha 31
Ningbo 30
Helsinki 28
Jinan 26
Dearborn 24
Falls Church 24
Brussels 23
Norwalk 23
Philadelphia 22
Shanghai 21
Los Angeles 18
Guangzhou 17
Taizhou 17
Hangzhou 16
Strasbourg 15
Lanzhou 14
Pune 14
Zhengzhou 14
Torre Del Greco 12
Dallas 11
Düsseldorf 11
Tappahannock 11
Fremont 9
Auburn Hills 6
Belfast 6
Brno 6
Changchun 6
Hefei 6
Munich 6
Toronto 6
Venezia 6
L’Aquila 5
Pescara 5
Shaoxing 5
Ancona 4
Houston 4
London 4
Napoli 4
Pavia 4
Redmond 4
Wuhan 4
Delhi 3
Florence 3
Fuzhou 3
Hanover 3
Miglianico 3
Rome 3
San Francisco 3
Turin 3
Abu Dhabi 2
Apice 2
Belgrade 2
Budapest 2
Casoria 2
Ceprano 2
Chisinau 2
Cicciano 2
Clifton 2
Dhaka 2
Fairfield 2
Haikou 2
Jinhua 2
Karaikal 2
Lanciano 2
Lima 2
Lugones 2
Madrid 2
Melbourne 2
Mumbai 2
Naples 2
Totale 9.240
Nome #
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression 107
ANTIANDROGENS AND 5-ALPHA REDUCTASE INHIBITION OF THE PROLIFERATION RATE IN PC3 AND DU145 HUMAN PROSTATIC-CANCER CELL-LINES 107
Serum 25(OH)D seasonality in urologic patients from central Italy 106
A gene expression signature from bone metastases as predictor of clinical outcome in breast cancer patients 97
Antiproliferative and pro-apoptotic effects of 5-azacytidine in prostate carcinoma cells in vitro involve the recovering of PTEN-mediated Akt activity control and androgen sensitivity 95
Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro 94
THE PROSTATIC MASSAGE YELDS VIABLE PROSTATIC EPITHELIAL CELLS AND MAY ALLOW AND EARLY DIAGNOSIS OF PROSTATIC CANCER IN VITRO 93
Trattamento con Casodex ed Iressa nel tumore della prostata: evidenze biologiche a favore 92
Obesity in the elderly - On the role of adipokines in prostate cancer progression 87
BOMBESIN- LIKE IMMUNOREACTIVE CELLS IN THE GENITAL SYSTEM OF ADULT MALE AND FEMALE RATS 87
Leptin contributes to long-term stabilization of HIF-1α in cancer cells subjected to oxygen limiting conditions 86
PROTEASE PRODUCTION (Upa AND METALLOPROTEINASES MMP-9) IN SHORT TERM CULTURE OF PROSTATIC CARCINOMA, CAN HAVE IMPORTANT DIAGNOSTIC AND PROGNOSTIC IMPLICATIONS. 84
Imipenem concentrations in human prostatic tissue: Clinical implications 83
Akt down-modulation induces apoptosis of human prostate cancer cells and synergizes with EGFR tyrosine kinase inhibitors 83
Human prostatic carcinoma in tissue culture: Correlations between histological diagnosis and in vitro parameters 83
Specific neurons of bran cortex and cerebellum are PIPPin-positive 82
Mitogen dose-dependent effect of weak pulsed electromagnetic field on lymphocyte blastogenesis. 82
Between-subject variations of transition zone epithelial volume and serum PSA levels in men with benign prostatic hyperplasia 81
Ricerche preliminari sull'azione del Desametazone e del Diflunisal nella flogosi sperimentale 81
Uncoupling of the epidermal growth factor receptor from downstream signal transduction molecules guides the acquired resistance to gefitinib in prostate cancer cells 81
Osteoblast-derived TGF beta-1 modulates matrix degrading protease expression and activity in prostate cancer cells (vol 85, pg 407, 2000) 81
Tissue print of prostate biopsy: a novel tool in the diagnostic procedure of prostate cancer 80
Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells 80
Antiproliferative and proapoptotic activities of new pyrazolo[3,4-d]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cells 80
Early diagnosis of prostatic carcinoma may be achieved through in vitro culture of tumor cells harvested by prostatic massage 80
L'acido valproico è un potente induttore di apoptosi nelle linee di carcinoma prostatico 80
UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) AND METALLOPROTEINASE (MMP-9) PRODUCTION IS IN-CREASED IN SHORT TERM CULTURES OF HUMAN PROSTATIC CARCINOMA. 80
Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitro 80
Early diagnosis of prostatic carcinoma based on in vitro culture of viable tumor cells harvested by prostatic massage 79
Stimulatory effect of hr tumor necrosis factor on TxB2 release by polymorphonuclears and macrophages. 79
Validity and limitations of a bimodal parametric approach for the evaluation of antibody affinity distributions 78
Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases 78
Gefitinib and bicalutamide show synergistic effects in primary cultures of prostate cancer derived from androgen-dependent naive patients 78
Aging influences the Value of Serum Leptin as Prostate Cancer Risk Factor 78
Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines 77
INIBITORI DI METALLOPROTEASI DI MATRICE: PROSPETTIVE TERAPEUTICHE. EOS - JOURNAL OF IMMUNOLOGY AND IMMUNOPHARMACOLOGY, VOL.XXI – 2001 – N.1: 22-27 77
La ridondanza delle vie di segnalazione intracellulari PI3K-AKT-MTOR induce la resistenza di cellule di cancro prostatico alla terapia ormonale ed ai chemoterapici in vivo ed in vitro 77
Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines 77
APOPTOSI E CANCRO DELLA PROSTATA 77
Effetto di Getifinib sulla crescita e la formazione di metastasi nel tumore della prostata in vivo 77
Valproic acid induces apoptosis in prostate carcinoma cell lines by activation of multiple death pathways 76
Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells 76
Melanoma cells stimulate osteoclastogenesis, c-src expression and osteoblast cytokines 76
Agar-specimen orientation technique revisited: a simple and effective method in histopathology 76
ESTABLISHMENT AND CHARACTERIZATION OF A HUMAN PROSTATIC-CARCINOMA CELL STRAIN OBTAINED FROM EXFOLIATED TUMOR-CELLS AFTER PROSTATIC MASSAGE 75
Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination 75
Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samples 75
Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro 75
INHIBITION OF 5-ALPHA-REDUCTASE ISOFORMS IN PROSTATE CARCINOMA PRIMARY CULTURES 75
Stimulatory effect of hr tumor necrosis factor on TXB2 release by polymorphnuclears and macrophages 75
Bicalutamide increases phospho-Akt levels through Her2 in patients with prostate cancer 75
Akt protein expression and activation in naive and antihormonal treated prostate cancer tissues 75
Changes in the immune response in the mouse following thermal shock. I. Humoral immunity 75
A new inhibitor of EGFR/SRC activation is able to block several key molecular events in prostate cancer progression 74
Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma 74
Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and Matrigel invasion 74
THE IMPACT OF SERUM LEPTIN AS BIOMARKER OF PROSTATE CANCER INCREASES WITH AGEING 74
Isolation of homogenous antibody populations by affinity chromatography 74
Long-term presence of androgens and anti-androgens modulate EGF-receptor expression and MAP-kinase phosphorylation in androgen receptor-prostate positive cancer cells 73
Arachidonic acid sustains prostate tumor growth in bone metastasis through the COX-2-mediated production of TNF-alpha 73
Kinase-dependent and independent role of EphA2 in the regulation of prostate cancer invasion and metastasis 73
Short-term tissue culture of prostatic carcinoma samples provides useful biological parameters related to patient prognosis 73
Type 5 Phosphodiesterase (PDE5) Expression in Human Vagina 73
Introductory Immunology 73
Receptor Activator of NF-kappa B Ligand Enhances Breast Cancer-Induced Osteolytic Lesions through Upregulation of Extracellular Matrix Metalloproteinase Inducer/CD147 72
Determination of imipenem in human plasma, urine and tissue by high-performance liquid chromatography 72
Synergistic activation of natural-killer activity by human recombinant interferon-alpha or interferon-gamma and indomethacin. 72
Increased matrix metalloproteinase-9 secretion in short-term tissue cultures of prostatic tumor cells 72
NEW 4-SUBSTITUTED DERIVATIVES OF PYRAZOLO [3,4-D] PYRIMIDINE AND PYRROLO [2,3-D] PYRIMIDINE AND USES THEREOF 72
Culture conditions modulate cell phenotype and cause selection of subpopulations in PC3 Prostate Cancer Cell Line 71
In vivo efficacy of HER1/EGFR tyrosine kinase inhibition in erlotinib resistant PC3 prostate cancer cells is associated to reduced endothelial cell organization and increased inflammatory infiltration 71
Effect of hrTNFalpha on TXB2 release by macrphages 71
Norfloxacin concentrations in seminal plasma measured by HPLC 71
L'aumento di neurotrofine è associato alla progressione del tumore della prostata in un modello animale murino 71
Anti-hormone treatments increase Akt protein expression and activation in prostate cancer 70
Indolyl-pyrrolone as a new scaffold for Pim1 inhibitors 70
"Trattamento della rinite allergica perenne (Dpt) con terapia iposensibilizzante a dose unica" 70
An overview of the effect of linoleic and conjugated-linoleic acids on the growth of several human tumor cell lines 70
Reactivation of androgen receptor and Fas: FASL signalling pathways by azacitidine treatment sensitizes aggressive prostate cancers to hormone manipulation and chemotherapy 70
FINASTERIDE DOSE-DEPENDENCY REDUCES THE PROLIFERATION RATE OF THE LNCAP HUMAN PROSTATIC-CANCER CELL-LINE IN-VITRO 69
Biotargets of Cancer in Current Clinical Practice 69
ATTIVITA’ CHEMIOTATTICA DEGLI OSTEOCLASI, TGF-BETA 1 MEDIATA, SU CELLULE DI CARCINOMA PROSTA-TICO IN VITRO 69
Bombesin-dependent Pro-MMP-9 activation in Prostatic Cancer cells requires beta-1 integrin engagement 68
Ruolo della finasteride nel controllo della proliferazione di colture primarie di carcinoma della prostata 68
“A two-year course of specific immunotherapy or of continuous antihistamine treatment reverse eosinophilic inflammation in severe persistent allergic rhinitis” 68
In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin 68
LA RIDONDANZA DELLE VIE DI SEGNALAZIONE INTRACELLULARI PI3K-AKT-MTOR INDUCE LA RESISTENZA DI CELLULE DI CANCRO PROSTATICO ALLA TERAPIA ORMONALE ED A CHEMOTERAPICI IN VIVO ED IN VITRO 68
Inhibition of tyrosine kinase c-Src improves experimental breast cancer metastatic disease. Implication for therapy 68
Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models 67
Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice 67
Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells 67
Improved tissue culture method for the study of prostatic carcinoma: a significant diagnostic tool 67
Co-evolution of stroma and neoplastic cells in prostate cancer is sustained by reprogramming energy metabolism 67
Characterization of prostate cancer DU145 cells expressing the recombinant androgen receptor 67
LA VALUTAZIONE DELL’ATTIVITA’ TELOMERASICA SU MASSAGGIO PROSTATICO PERMETTE DI MIGLIORARE LA DIFFERENZIAZIONE TRA LA PATOLOGIA TUMORALE PROSTATICA E L’IPERPLASIA PROSTATICA BENIGNA 67
Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cells 67
Identification of a novel pyrazolo[3,4-d]pyrimidine able to inhibit cell proliferation of a human osteogenic sarcoma in vitro and in a xenograft model in mice 67
Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures 66
Bicalutamide dose-dependently inhibits proliferation in human prostatic carcinoma cell lines and primary cultures 66
Surgical and Biologic Outcomes After Neoadjuvant Bicalutamide Treatment in Prostate Cancer 66
Totale 7.632
Categoria #
all - tutte 54.302
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.302


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.103 0 0 0 0 8 250 309 20 229 43 15 229
2020/20211.801 36 216 5 226 217 76 232 9 224 86 398 76
2021/20221.353 89 160 266 91 59 15 17 82 66 37 93 378
2022/20233.927 284 159 61 370 467 455 3 259 1.671 31 102 65
2023/2024774 127 53 47 181 56 190 18 40 1 18 10 33
2024/2025919 58 53 335 91 382 0 0 0 0 0 0 0
Totale 13.697